Enhanced detection of early hepatocellular carcinoma by serum SELDI-TOF proteomic signature combined with alpha-fetoprotein marker.

Enhanced detection of early hepatocellular carcinoma by serum SELDI-TOF proteomic signature combined with alpha-fetoprotein marker.

Item
http://www.wikidata.org/entity/Q33547822
Implications of biomarkers in human hepatocellular carcinoma pathogenesis and therapyA pilot study to investigate the potential of mass spectrometry profiling in the discovery of novel serum markers in chronic renal disease.Classification of Traditional Chinese Medicine Syndromes in Patients with Chronic Hepatitis B by SELDI-Based ProteinChip Analysis.Cancer-associated carbohydrate antigens as potential biomarkers for hepatocellular carcinoma.Identification of serum monocyte chemoattractant protein-1 and prolactin as potential tumor markers in hepatocellular carcinoma.Multi-TGDR, a multi-class regularization method, identifies the metabolic profiles of hepatocellular carcinoma and cirrhosis infected with hepatitis B or hepatitis C virusIdentification of Candidate Serum Biomarkers for Schistosoma mansoni Infected Mice Using Multiple Proteomic Platforms.Chromatographic determination of some biomarkers of liver cirrhosis and hepatocellular carcinoma in Egyptian patients.Serum miR-96 is a promising biomarker for hepatocellular carcinoma in patients with chronic hepatitis B virus infection.Serum biomarkers identification by mass spectrometry in high-mortality tumors.Variation in serum biomarkers with sex and female hormonal status: implications for clinical testsCombining multiple serum biomarkers in tumor diagnosis: A clinical assessment.Dysregulated expression of dickkopfs for potential detection of hepatocellular carcinoma.Biomarkers for hepatocellular carcinoma: diagnostic and therapeutic utility.Tissue transglutaminase 2 exerts a tumor-promoting role in hepatitis B virus-related hepatocellular carcinoma.A Surgical Perspective on Targeted Therapy of Hepatocellular Carcinoma.Development of a novel score for early detection of hepatocellular carcinoma among high-risk hepatitis C virus patients.
P2860

Enhanced detection of early hepatocellular carcinoma by serum SELDI-TOF proteomic signature combined with alpha-fetoprotein marker.

Item
http://www.wikidata.org/entity/Q33547822
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Enhanced detection of early he ...... with alpha-fetoprotein marker.
@ast
Enhanced detection of early he ...... with alpha-fetoprotein marker.
@en
Enhanced detection of early he ...... with alpha-fetoprotein marker.
@nl
type
label
Enhanced detection of early he ...... with alpha-fetoprotein marker.
@ast
Enhanced detection of early he ...... with alpha-fetoprotein marker.
@en
Enhanced detection of early he ...... with alpha-fetoprotein marker.
@nl
prefLabel
Enhanced detection of early he ...... with alpha-fetoprotein marker.
@ast
Enhanced detection of early he ...... with alpha-fetoprotein marker.
@en
Enhanced detection of early he ...... with alpha-fetoprotein marker.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P5875
P6179
P698
P921
P932
P356
P1433
P1476
Enhanced detection of early he ...... with alpha-fetoprotein marker
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P5875
P6179
P698
P921
P932